Liposomes Part 3: Evaluation & Characterization Methods

Added:

The Synthetic vs. Biological Identity Disconnect in Liposome Characterization

While standard physical and chemical characterization methods (such as Dynamic Light Scattering for size and zeta potential for charge) are crucial for pharmaceutical quality control, critics argue they only measure a liposome's 'synthetic identity' which poorly predicts in vivo behavior. Upon entering physiological systems, liposomes are immediately coated by biomolecules, forming a dynamic 'protein corona.' This biological coating fundamentally alters the liposomes' size, charge, and targeting capabilities, rendering pristine in vitro measurements obsolete. Additionally, traditional evaluation techniques are often 'ensemble methods' that provide average values, masking the critical heterogeneity of individual nanoparticles. Proponents of this critique advocate for characterizing liposomes directly within complex biological media and adopting single-particle analysis to bridge the critical in vitro-in vivo correlation (IVIVC) gap.

The fundamental structure and composition of liposomes, including the role of phospholipids, cholesterol, and lipid bilayers.
Basic preparation techniques for liposomes, such as thin-film hydration, ether injection, and extrusion, to understand the origin of sample heterogeneity.
Core concepts of physical chemistry, specifically colloidal stability, Brownian motion, and the concept of electrostatic repulsion (zeta potential).
Basic principles of spectrophotometry and chromatography (e.g., HPLC) used for quantifying encapsulated therapeutic agents.
In vivo pharmacokinetics and biodistribution, exploring how liposome size and surface charge influence clearance by the mononuclear phagocyte system (MPS).
Advanced surface engineering of liposomes, such as PEGylation (stealth liposomes) and active targeting using ligands or antibodies.
Industrial scale-up, Quality Control (QC) validation, and regulatory approval pathways for liposomal drug products (e.g., FDA guidelines).
Clinical applications of liposomal systems, analyzing real-world therapeutics like Doxil/Caelyx and AmBisome.
10.6K views172likes17:26@pharmatricksforexams5967Original Release: 2022-02-22

Liposome evaluation encompasses three main categories: physical characterization (including size, size distribution, shape, surface charge, lamellarity, and phase behavior determined by techniques like laser light scattering, transmission electron microscopy, electrophoresis, and differential scanning calorimetry); chemical characterization (assessing phospholipid content via colorimetric assays, cholesterol content via HPLC, drug content using UV-visible spectroscopy, and detecting lipid peroxidation); and biological characterization (evaluating sterility, pyrogenicity, and animal toxicity). Key parameters include entrapment efficiency (calculated as [(initial drug - free drug)/initial drug] × 100) and percentage drug loading (calculated as [entrapped drug/total liposome weight] × 100), which are essential for pharmaceutical quality control and formulation optimization.